Kewajiban jangka dawa perusahaan: Omada Health, Inc. (OMDA)

Logo grafis Omada Health Corp (OMDA)

Omada is demonstrating sustainable growth by expanding its corporate segment and creating high barriers to entry for competitors. However, dependence on large insurance contracts and pressure from free services pose certain threats. The asset's market trend, examined on the price chart, is accompanied by the indicator 0.00. The business is focusing on combating obesity and diabetes, implementing AI technologies to optimize employer costs.

Utang jangka dawa perusahaan Omada Health, Inc. (OMDA): kanggo periode 07.06.2025 - 29.10.2026
Produk asil prodhuksi Omada Health Inc

This metric aggregates obligations with maturities exceeding one year, reflecting the cost of debt and the balance sheet structure's resilience to interest rate fluctuations. For Omada Health Inc (OMDA), controlling this volume is critical during the transition from current insurance payouts to the capital-intensive scaling of digital platforms, making changes in the company's long-term debt an indicator of its readiness for expansion.

Karo sapa Omada Health Inc saingan

Silihan lan utang jangka dawa perusahaan VEEV|DOCS - Utang jangka dawa perusahaan|HealthEquity Inc (HQY) - Kewajiban jangka dawa perusahaan|WAY: Utang jangka dawa perusahaan|Utang jangka dawa CorVel Corp. (CRVL)|PRVA (Privia Health Group) - Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan HURN (huronconsultinggroup.com)|Utang jangka dawa perusahaan Certara (CERT)|OMCL - Utang jangka dawa|Utang jangka dawa perusahaan GoodRx Corp GDRX|SDGR - Kewajiban jangka dawa perusahaan|Phreesia, Inc. - Utang jangka dawa perusahaan|EVH - Utang jangka dawa perusahaan|HSTM: Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan DH|CCSI (Consensus) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Agilon Health Corp|Kewajiban jangka dawa perusahaan ABSI (Absci)|SY (soyoung.com) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan NRC (National Research Corp)|Silihan lan utang jangka dawa perusahaan SPOK|OptimizeRx Corp. - Utang jangka dawa perusahaan|Utang jangka dawa TruBridge Corp|SLP: Utang jangka dawa perusahaan|SOPHiA GENETICS (SOPH) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Health Catalyst|Utang jangka dawa perusahaan CCLD|Kewajiban jangka dawa perusahaan RSSS (Research Solutions)|Gedhene kewajiban jangka dawa DLHC|Utang jangka dawa perusahaan ONMD (OneMedNet)|Silihan lan utang jangka dawa perusahaan SCNX|HCTI: Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan ISPC (iSpecimen Inc.)|BFRG: Utang jangka dawa perusahaan|WORX - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan MSP Recovery Inc|Tanggungan utang jangka dawa perusahaan ICCT (iCoreConnect Corp)|Utang jangka dawa perusahaan MEDS|Kewajiban jangka dawa perusahaan Orgenesis Inc ORGS|Utang jangka dawa perusahaan R1 RCM RCM|Sharecare Inc (SHCR) - Utang jangka dawa|STRM - Utang jangka dawa perusahaan|syrahealth.com (SYRA) - Kewajiban jangka dawa perusahaan|AMEH: Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan MODN|NXGN (NextGen) - Utang jangka dawa perusahaan